Lifevantage Target of Unusually Large Options Trading (NASDAQ:LFVN)

Lifevantage Corporation (NASDAQ:LFVN) was the recipient of some unusual options trading activity on Wednesday. Traders purchased 2,482 call options on the stock. This represents an increase of 747% compared to the average daily volume of 293 call options.

Insider Activity

In other Lifevantage news, Director Judd Dayton purchased 18,097 shares of Lifevantage stock in a transaction that occurred on Friday, February 27th. The stock was bought at an average price of $4.63 per share, with a total value of $83,789.11. Following the acquisition, the director owned 69,859 shares of the company’s stock, valued at $323,447.17. This trade represents a 34.96% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In the last ninety days, insiders have acquired 34,252 shares of company stock valued at $157,940. Insiders own 21.95% of the company’s stock.

Hedge Funds Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently modified their holdings of the business. Jane Street Group LLC boosted its position in Lifevantage by 5.4% during the first quarter. Jane Street Group LLC now owns 36,567 shares of the company’s stock worth $533,000 after acquiring an additional 1,877 shares during the last quarter. Cetera Investment Advisers raised its holdings in Lifevantage by 10.8% in the 2nd quarter. Cetera Investment Advisers now owns 20,098 shares of the company’s stock valued at $263,000 after acquiring an additional 1,954 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in Lifevantage by 11.9% in the 1st quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company’s stock valued at $145,000 after acquiring an additional 3,571 shares during the last quarter. Invesco Ltd. lifted its stake in Lifevantage by 13.6% in the 4th quarter. Invesco Ltd. now owns 30,085 shares of the company’s stock worth $185,000 after purchasing an additional 3,603 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock worth $66,000 after purchasing an additional 4,499 shares in the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on LFVN shares. Weiss Ratings lowered Lifevantage from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. Loop Capital set a $5.00 price objective on shares of Lifevantage in a research report on Thursday, February 5th. Finally, Lake Street Capital downgraded shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price objective on the stock. in a report on Thursday, May 7th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $5.00.

Lifevantage Trading Up 9.1%

NASDAQ:LFVN traded up $0.63 during trading hours on Wednesday, hitting $7.56. 401,071 shares of the stock were exchanged, compared to its average volume of 196,553. The firm’s fifty day moving average price is $4.85 and its 200 day moving average price is $5.53. Lifevantage has a 52-week low of $3.90 and a 52-week high of $15.00. The company has a market cap of $95.46 million, a P/E ratio of 16.57 and a beta of 0.52.

Lifevantage (NASDAQ:LFVN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.04). Lifevantage had a return on equity of 23.89% and a net margin of 2.94%.The firm had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Equities analysts expect that Lifevantage will post 0.6 EPS for the current fiscal year.

Lifevantage Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, June 1st. This is a positive change from Lifevantage’s previous quarterly dividend of $0.05. This represents a $0.20 dividend on an annualized basis and a dividend yield of 2.6%. Lifevantage’s payout ratio is currently 40.00%.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.